{
  "content": "Amiodarone is contraindicated in cases of severe sinus node dysfunction with notable sinus bradycardia or syncope, second- or third-degree heart block, known hypersensitivity, cardiogenic shock, and likely severe chronic lung disease. The prevalent adverse effects encompass sinus bradycardia, particularly in older individuals, and QT prolongation . However, the occurrence of torsades de points is extremely rare [ 2]. This can be explained by amiodarone’s unique mechanism of action. Amiodarone has properties of all four classes of antiarrhythmics and is unique from other class III drugs. It blocks multiple ion channels, including potassium, sodium, and calcium, which prolong the action potential without significantly increasing the dispersion of ventricular repolarization [ 1,2 ]",
  "source": "https://pdfs.semanticscholar.org/eda9/09ebe34c58658072d9d3a1e6db13d581c6cd.pdf?skipShowableCheck=true",
  "chunk_id": "b1fa8a29-c9ed-4933-a18e-5b5e62c80317",
  "similarity_score": 0.21193718910217285,
  "query": "beta-blockers safety profile atrial fibrillation heart failure contraindications bradycardia hypotension",
  "rank": 14,
  "title": "Amiodarone Therapy: Updated Practical Insights",
  "authors": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărașu, B. C., Diaconu, A.-D., Sorodoc, L.",
  "year": "2024",
  "journal": "Journal of Clinical Medicine",
  "reference": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărașu, B. C., Diaconu, A.-D., & Sorodoc, L. (2024). Amiodarone therapy: Updated practical insights. Journal of Clinical Medicine, 13(20), 6094. https://doi.org/10.3390/jcm13206094",
  "doi": "10.3390/jcm13206094",
  "chunk_index": 68,
  "total_chunks": 209,
  "retrieved_at": "2025-07-24T21:57:55.188527"
}